AI Policy Roundup: ARPA-H Backs Agentic Care, FDA Creates AI Leadership Role, and Congress Weighs New Oversight

AI Policy Roundup: ARPA-H Backs Agentic Care, FDA Creates AI Leadership Role, and Congress Weighs New Oversight

In our latest artificial intelligence (AI) policy roundup, we cover recent federal developments across health care AI, agentic AI, cybersecurity, liability, congressional oversight, and technical standards. Health care remains an increasingly prominent area of federal AI activity, with ARPA-H launching a major effort to develop FDA-authorized agentic AI for cardiovascular care, FDA creating its first agency-wide technology and AI leadership… (Colocho, September 11, 2026) #Artificial Intelligence, #Food and Drug Administration, #Grants